CLINICAL OBSERVATIONS ON THE USE OF PROSTIGMIN IN THE TREATMENT OF MYASTHENIA GRAVIS.
作者信息
Laurent L P
出版信息
Br Med J. 1935 Mar 9;1(3870):463-5. doi: 10.1136/bmj.1.3870.463.
Abstract
摘要
相似文献
1
CLINICAL OBSERVATIONS ON THE USE OF PROSTIGMIN IN THE TREATMENT OF MYASTHENIA GRAVIS.
Br Med J. 1935 Mar 9;1(3870):463-5. doi: 10.1136/bmj.1.3870.463.
2
[Acute effect of prostigmin on lung function and breathing of patients with myasthenia gravis at rest and following ergometric exercise].
Respiration. 1987;52(1):59-68. doi: 10.1159/000195305.
3
The relative merits of prostigmin and mestinon in the treatment of myasthenia gravis.
J Egypt Med Assoc. 1956 Jun 21;39(3):240-51.
4
The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London.
J Hist Neurosci. 2005 Jun;14(2):121-37. doi: 10.1080/096470490512580.
5
Myasthenia Gravis: Its Treatment by a Combination of Prostigmin and Glycine-Ephedrine Therapy.
Glasgow Med J. 1937 Jul;128(1):7-11.
6
Case showing the Effect of Prostigmin on Myasthenia Gravis.
Proc R Soc Med. 1935 Apr;28(6):759-61. doi: 10.1177/003591573502800633.
7
The Mary Walker effect: Mary Broadfoot Walker.
J R Coll Physicians Edinb. 2019 Sep;49(3):255-259. doi: 10.4997/JRCPE.2019.317.
8
Combined use of neostigmine and ocular motility measurements in the diagnosis of myasthenia gravis.
Arch Ophthalmol. 1982 May;100(5):761-3. doi: 10.1001/archopht.1982.01030030765008.
9
Mary B. Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis.
Doc Ophthalmol. 1997;93(1-2):125-34. doi: 10.1007/BF02569052.
10
The effect of prostigmin on the basal electromyogram in myasthenia.
Pol Med J. 1970;9(3):730-7.
引用本文的文献
1
Current Treatment of Myasthenia Gravis.
J Clin Med. 2022 Mar 14;11(6):1597. doi: 10.3390/jcm11061597.
2
The miracle at St Alfege's: seventy years on.
J R Soc Med. 2007 Feb;100(2):108-9. doi: 10.1177/014107680710000230.
Zotero 插件